JioHotstar Series Questions India's Pharmaceutical System
JioHotstar's new series 'Pharma' ignites public debate on drug pricing, ethics, and accessibility in India's healthcare system. Read the full analysis.
Category : Search result: Indian pharmaceutical companies
India Pharma Targets $500B, Innovation Hub by 2047
India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
Govt's Data Exclusivity Push May Hit Cheap Generic Drugs
The Indian government is considering data exclusivity for pharma, a move that could delay cheap generic drugs, impact India's global edge, and affect medicine access. Read the full analysis.
Trump's Deal with 9 Pharma Firms to Cut US Drug Prices
US President Donald Trump announces agreements with nine major pharmaceutical companies to lower prescription drug prices, aligning US costs with other wealthy nations. Key details inside.
Trump Announces Drug Price Deals, Launches TrumpRx.gov
President Trump announces agreements with 9 drug firms to lower prices via new portal TrumpRx.gov. Will it cut costs for Americans? Details on the plan, participating companies, and expert analysis.
Trump's Deal with 9 Pharma Firms to Cut US Drug Prices
US President Donald Trump secures agreements with nine major pharmaceutical companies to reduce Medicaid and cash-pay drug prices, aiming to align US costs with other wealthy nations. Details inside.
Trump Announces New Drug Price Agreements Dec 19
US President Donald Trump will announce new pacts with major drugmakers like AbbVie & Merck to lower prescription costs. Details on the 'most-favored-nation' push here.
Pfizer, Cipla announce 5-year partnership for 4 key brands
Pfizer India and Cipla announce a 5-year partnership. Cipla will exclusively market and distribute four key Pfizer brands in India, aiming to expand patient reach nationwide. Read details.
Govt Imposes Price Floor on Drug APIs to Curb Cheap Imports
Himachal Pradesh govt introduces Minimum Import Price on potassium clavulanate & intermediates till Nov 2026 to shield Indian API makers from cheap Chinese imports. Read details.
Odisha Pharma Summit 2025 garners Rs 7,043 crore proposals
Odisha CM Mohan Majhi positions state as top pharma & medical devices investment destination. New policy & parks attract Rs 7,043 crore proposals, 45 MoUs signed. Read more.
Shark Tank's Mittal on Ozempic Launch & 2026 Pharma Shift
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
NHS to pay 25% more for drugs in US trade deal
The UK's NHS will pay 25% more for innovative drugs in a new US trade deal, costing £3bn over three years. In return, UK pharma exports to the US avoid hefty tariffs. Read the full analysis.
US Grants UK 3-Year Tariff Exemption on Pharma Imports
The US extends a critical tariff exemption for UK pharmaceutical and medical technology imports for three years, supporting supply chains and public health. Read the full analysis.
Wockhardt's Zaynich NDA Accepted by USFDA, Shares Soar 19%
Mumbai's Wockhardt creates history as USFDA accepts its New Drug Application for antibiotic Zaynich, a first for an Indian firm. Shares surge 19%. Read more.
2 Lakh+ Private Firms Closed in India in 5 Years
Government data reveals 2,04,268 private companies closed in India from 2020-21 to 2024-25. No employee rehabilitation plan exists. Read the full report on the corporate clean-up drive.
Wockhardt Stock Jumps on US FDA Nod for Novel Antibiotic
Wockhardt shares surged 19.3% after US FDA accepted its New Drug Application for Zaynich, a first-in-class antibiotic. This marks a historic first for an Indian pharma company's New Chemical Entity.
Mumbai bizwoman assaulted by pharma officials
A 51-year-old Mumbai businesswoman was held at gunpoint, stripped and threatened by pharmaceutical company executives. Mumbai Police registers case under multiple sections.
Father of Codeine Trafficking Kingpin Arrested at Airport
Kolkata Police arrests Bhola Prasad, father of absconding pharmaceutical dealer Shubham Jaiswal, in UP's multi-state codeine trafficking investigation. Read the full story.
UP busts ₹150 crore pharma narcotics racket
Uttar Pradesh authorities uncover massive pharmaceutical diversion network smuggling codeine-based cough syrups as narcotics across 7 states and borders. 87 firms face FIRs in chilling organized crime operation.
NCB Issues Warrants in ₹600 Crore Drug Racket
NCB obtains non-bailable warrants against Digital Vision owners in massive ₹600 crore drug diversion case. Key accused involved in international pharmaceutical fraud uncovered in Himachal Pradesh.
12 Pharma Firms Booked in UP Cough Syrup Smuggling Case
Uttar Pradesh government intensifies crackdown on cough syrup smuggling, registers cases against 12 pharmaceutical companies. Investigation reveals interstate smuggling network.
Freudenberg's Pharma Innovations at CPhI PMEC India 2025
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced single-use systems and filtration technologies.
Freudenberg Highlights Pharma Innovations at CPhI PMEC 2025
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced drug delivery systems and filtration technologies.
Sudeep Pharma Shares Jump 33% After Strong IPO Listing
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma IPO Lists Today with Strong Grey Market Premium
Sudeep Pharma shares list on BSE and NSE today after 93.72 times subscription. Grey market signals 20% premium debut. Full details on pricing and investor response.
India's Top 10 IT Companies by Market Cap in 2025
Discover the top 10 Indian IT companies by market cap in 2025. TCS leads the ranking with a massive Rs 11.25 lakh crore valuation, followed by Infosys and HCL Tech. Explore the list now!
SMS Pharma Shares Jump 17% After USFDA Nod for Ranitidine
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
Sudeep Pharma IPO Allotment Status Today
Sudeep Pharma IPO allotment finalized today after massive 93.71x subscription. GMP at ₹87 signals 14.67% listing gain. Track your allotment status now!
Indian Pharma Pivots to Innovative Products: PHARMEXCIL
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Sudeep Pharma IPO Subscribed 94 Times
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.
Page 1 of 4